Chronic Hepatitis C and Direct Acting Antivirals

Surgical Pathology Clinics
Maria Westerhoff, Joseph Ahn

Abstract

The hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is the most common cause of end-stage liver disease requiring liver transplant. Over the last 10 years, direct acting antiviral therapies have revolutionized HCV treatment, increasing the cure rates from less than 50% to more than 90% in those who reach access to care. This article is an overview for pathologists and clinicians covering the histologic findings of HCV as well as direct acting antiviral therapy.

Citations

Mar 9, 2019·Reviews on Recent Clinical Trials·Riccardo ScottoGuglielmo Borgia
Aug 4, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Christine ChanJosh Levitsky
Apr 5, 2019·Expert Opinion on Investigational Drugs·Guglielmo BorgiaAntonio Riccardo Buonomo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.